A comparative study on inter and intralaboratory reproducibility of renin measurement with a conventional enzymatic method and a new chemiluminescent assay of immunoreactive renin

Journal of Hypertension

Volumn 28, Issue 6, 2010, Pages 1307-1312

  Morganti, Alberto ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Chemiluminescent immunoreactive renin; Inter and intralaboratory reproducibility; Plasma renin activity

Indexed keywords

RENIN;

ANALYTIC METHOD; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; ENZYME ANALYSIS; ENZYME ASSAY; HUMAN; IMMUNOREACTIVITY; INTERMETHOD COMPARISON; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; REFERENCE VALUE; RELIABILITY; REPRODUCIBILITY;

EID: 77952553440     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32833857ad     Document Type: Article

References (26)

1. Sealey JE. Plasma renin activity and plasma prorenin assays. Clin Chem 1991; 37:1811-1819.
2. Bangham DR, Robertson I, Robertson JIS, Robinson CJ, Tree M. An international collaborative study on renin assay: establishment of the international reference preparation of human renin. Clin Sci Mol Med Suppl 1975; 2:S135-S159.
3. Galen FX, Devaux C, Atlas S, Guyenne T, Ménard J, Corvol P, et al. New monoclonal antibodies directed against human renin. Powerful tools of the investigation of the renin system. J Clin Invest 1984; 74:723-735.
4. Ménard J, Guyenne T, Corvol P, Pau B, Simon D, Roncucci R. Direct immunometric assay of active renin in human plasma. J Hypertens 1985; 3 (Suppl 3):S275-S278.
5. Morganti A, Turolo L, Pulazzini E, Zanchetti A. Comparative measurements of immunoreactive renin, plasma renin activity and angiotensin II in human plasma. Clin Exp Hypertens 1987; 9:1367-1381.
6. Shionoiri H, Takasaki I, Ishikawa Y, Minamisawa K, Sugimoto K, Hirawa N, et al. Measurement of plasma renin activity by solid phase radioimmunoassay using monoclonal antibodies. Am J Med Sci 1990; 300:138-143.
7. Morganti A, Pelizzola D, Mantero F, Gazzano G, Opocher G, Piffanelli A, on behalf of the Italian Multicenter Study for Standardization of Renin Measurement. Immunoradiometric versus enzymatic renin assay: results of the Italian Multicenter Comparative Study. J Hypertens 1995; 13:19-26.
8. Sealey JE, Trenkwalder P, Gahnem F, Catanzaro D, Laragh JH. Plasma renin methodology: inadequate sensitivity and accuracy of direct renin assay for clinical applications compared with the traditional enzymatic plasma renin activity assay. J Hypertens 1995; 13:27-30.
9. Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, et al. Case detection, diagnosis and treatment of patients with primary hyperaldosteronism: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2008; 93:3266-3281.
10. De Bruin RA, Bouhuizen A, Diederich S, Perschel FH, Boosma F, Deinum J. Validation of a new automated renin assay. Clin Chem 2004; 50:2111-2116.
11. Hartman D, Sagnella GA, Chesters CA, McGregor GA. Direct renin assay and plasma renin activity assay compared. Clin Chem 2004; 50:2159-2161.
12. DiaSorin. LIAISON. Direct renin. www.diasorin.com/upload/ prodottiesistemi/Direct%20Renin.pdf. [Accessed 24 July 2008]
13. GloriosoN,Dess̀i-FulgheriP, Madeddu P, Oppes M, Palermo M, Mancia G, et al. A reevaluation of methodological aspects of a commercial RIA kit for plasma renin activity. J Nucl Med Allied Sci 1985; 29:235-239.
14. Deinum J, Derkx FHM, Schalekamp MADH. Improved immunoradiomentric assay for plasma renin. Clin Chem 1999; 45:847-854.
15. Paulsen K, Jorgenson J. An easy radioimmunological microassay of renin activity, concentration and substrate in human and animal plasma and tissue based on angiotensin I trapping by antibody. J Clin Endocrinol Metab 1974; 39:816-825.
16. Nussberger J, Fasanella D'Amore T, Porchet M, Waeber B, Brunner DB, Brunner HR, et al. Repeated administration of the converting enzyme inhibitor cilazapril to normal volunteers. J Cardiovasc Pharmacol 1987; 9:39-44. (Pubitemid 17212750)
17. Sealey JE, Gordon RD, Mantero F. Plasma renin and aldosterone measurements in low renin hypertensive states. Trends Endocrinol Metab 2005; 16:86-91.
18. Iervasi A, Zucchelli GC, Turchi S, Emdin M, Passino C, Ripoli A, Clerico A. Analytical and clinical performance of an automated chemiluminescent, immunoassay for direct renin measurement: comparison with PRA and aldosterone assays. Immunoanal Biol Special 2005; 20:257-262.
19. Campbell DJ, Nussberger J, Stowasser M, Danser AHJ, Morganti A, Frandsen E, Mé nard J. Activity assays and immunoassays for plasma renin and prorenin: information provided and precautions necessary for accurate measurement. Clin Chem 2009; 55:867-877.
20. Ménard J, Guyenne TT, Peyrard S, Azizi M. Conformational changes in prorenin during renin incubation in vitro and in vivo. J Hypertens 2006; 24:529-534.
21. Campbell DJ. Interpretation of plasma renin concentration in patients receiving aliskiren therapy. Hypertension 2008; 51:15-18.
22. Schalekamp MA, Derkx FH, Deinum J, Danser AJ. Newly developed renin and prorenin assays and the clinical evaluation of renin inhibitors. J Hypertens 2008; 26:928-937.
23. Perschel FH, Schemer R, Seiler L, Reincke M, Deinum J, Maser-Gluth C, et al. Rapid screening test for primary hyperaldosteronism: ratio of plasma aldosterone to renin concentration determined by fully automated chemiluminescence immunoassays. Clin Chem 2004; 50:1650-1655.
24. Lonati C, Patalano A, De Toni R, Marano G, Morganti A. Direct versus enzymatic renin measurement for the calculation of aldosterone/renin ratio in patients with essential hypertension and with primary hyperaldosteronism [abstract]. J Hypertens 2009; 27 (Suppl 4):S445.
25. Olivieri O, Ciacciarelli A, Signorelli D, Pizzolo F, Guarini P, Pavan C, et al. Aldosterone to renin ratio in a primary care setting: the Bussolengo Study. J Clin Endocrinol Metab 2004; 89:4221-4226.
26. Ménard J, Guyenne T. Commentary: Renin assays: a debate for clinicians, not only for specialists. J Hypertens 1995; 13:367-369.